Hannah M Phelps1, Janene M Pierce2, Andrew J Murphy3, Hernan Correa4, Jun Qian5, Pierre P Massion5, Harold N Lovvorn2. 1. Vanderbilt University School of Medicine, Nashville, TN. Electronic address: hannah.m.phelps@vanderbilt.edu. 2. Vanderbilt University Medical Center, Department of Pediatric Surgery, Nashville, TN. 3. St. Jude Children's Research Hospital, Department of Surgery, Memphis, TN. 4. Vanderbilt University Medical Center, Department of Pathology, Microbiology, and Immunology, Nashville, TN. 5. Vanderbilt University Medical Center, Department of Medicine and Vanderbilt Ingram Cancer Center, Nashville, TN.
Abstract
BACKGROUND/ PURPOSE: Wilms tumor (WT) is the most common childhood kidney cancer globally. Our prior unbiased proteomic screen of WT disparities revealed increased expression of Fragile X-Related 1 (FXR1) in Kenyan specimens where survival is dismal. FXR1 is an RNA-binding protein that associates with poor outcomes in multiple adult cancers. The aim of this study therefore was to validate and characterize the FXR1 expression domain in WT. METHODS: Quantitative FXR1 gene expression was compared between WT, adjacent, adult, and fetal kidney specimens. The cellular and subcellular expression domain of FXR1 was characterized across these tissues using immunoperoxidase staining. RNA-sequencing of FXR1 was performed from WT and other pediatric malignancies to examine its broader target potential. RESULTS: FXR1 was detected in all clinical WT specimens evaluated (n = 82), and as a result appeared independent of demographic, histology, or adverse event. Specific cytosolic staining was strongest in blastema, intermediate and variable in epithelia, and weakest in stroma. When present, areas of skeletal muscle differentiation stained strongly for FXR1. qPCR revealed increased FXR1 expression in WT compared to adult and adjacent kidney (p < 0.0002) but was similar to fetal kidney (p = 0.648). RNA-sequencing revealed expression of FXR1 in multiple pediatric tumors, greatest in rhabdomyosarcoma and WT. CONCLUSIONS: FXR1 was expressed consistently across this broad sampling of WT and most robustly in the primitive blastema. Notably, FXR1 labeled a specific self-renewing progenitor population of the fetal kidney.
BACKGROUND/ PURPOSE: Wilms tumor (WT) is the most common childhood kidney cancer globally. Our prior unbiased proteomic screen of WT disparities revealed increased expression of Fragile X-Related 1 (FXR1) in Kenyan specimens where survival is dismal. FXR1 is an RNA-binding protein that associates with poor outcomes in multiple adult cancers. The aim of this study therefore was to validate and characterize the FXR1 expression domain in WT. METHODS: Quantitative FXR1 gene expression was compared between WT, adjacent, adult, and fetal kidney specimens. The cellular and subcellular expression domain of FXR1 was characterized across these tissues using immunoperoxidase staining. RNA-sequencing of FXR1 was performed from WT and other pediatric malignancies to examine its broader target potential. RESULTS: FXR1 was detected in all clinical WT specimens evaluated (n = 82), and as a result appeared independent of demographic, histology, or adverse event. Specific cytosolic staining was strongest in blastema, intermediate and variable in epithelia, and weakest in stroma. When present, areas of skeletal muscle differentiation stained strongly for FXR1. qPCR revealed increased FXR1 expression in WT compared to adult and adjacent kidney (p < 0.0002) but was similar to fetal kidney (p = 0.648). RNA-sequencing revealed expression of FXR1 in multiple pediatric tumors, greatest in rhabdomyosarcoma and WT. CONCLUSIONS: FXR1 was expressed consistently across this broad sampling of WT and most robustly in the primitive blastema. Notably, FXR1 labeled a specific self-renewing progenitor population of the fetal kidney.
Authors: Peter E Clark; Dina Polosukhina; Harold Love; Hernan Correa; Cheryl Coffin; Elizabeth J Perlman; Mark de Caestecker; Harold L Moses; Roy Zent Journal: Am J Pathol Date: 2011-10-08 Impact factor: 4.307
Authors: Andrew J Murphy; Jason R Axt; Christian de Caestecker; Janene Pierce; Hernan Correa; Erin H Seeley; Richard M Caprioli; Mark W Newton; Mark P de Caestecker; Harold N Lovvorn Journal: Int J Cancer Date: 2012-04-04 Impact factor: 7.396
Authors: Harold N Lovvorn; Jenifer Westrup; Shaun Opperman; Scott Boyle; Genbin Shi; James Anderson; Elizabeth J Perlman; Alan O Perantoni; Marcia Wills; Mark de Caestecker Journal: Neoplasia Date: 2007-07 Impact factor: 5.715
Authors: Chi-Ming Li; Meirong Guo; Alain Borczuk; Charles A Powell; Michelle Wei; Harshwardhan M Thaker; Richard Friedman; Ulf Klein; Benjamin Tycko Journal: Am J Pathol Date: 2002-06 Impact factor: 4.307
Authors: Edwin J Mientjes; Rob Willemsen; Laura L Kirkpatrick; Ingeborg M Nieuwenhuizen; Marianne Hoogeveen-Westerveld; Marcel Verweij; Surya Reis; Barbara Bardoni; Andre T Hoogeveen; Ben A Oostra; David L Nelson Journal: Hum Mol Genet Date: 2004-05-05 Impact factor: 6.150
Authors: Laura Nordio; Chiara Bazzocchi; Francesca Genova; Valentina Serra; Maria Longeri; Giovanni Franzo; Marco Rondena; Damiano Stefanello; Chiara Giudice Journal: Front Vet Sci Date: 2021-12-13